A photo of Lori Crosby.

Lori E. Crosby, PsyD


  • Co-Director, Innovations in Community Research, Division of Behavioral Medicine and Clinical Psychology
  • Director, CCTST, Community Engagement Core
  • Psychologist, Research, Division of Behavioral Medicine and Clinical Psychologist
  • Professor, UC Department of Pediatrics
I chose to do research because I wanted to help as many children and families as I could. With my research, I strive to learn the best ways for the medical team and patients and families to work together to improve treatment and the family's quality of life.
Lori E. Crosby, PsyD

About

Biography

I am a clinical psychologist and researcher. In my patient care, I specialize in treating adolescents and young adults with conditions such as chronic pain and sickle cell disease. I seek to help them with managing their disease, treatment adherence and transitioning to adult healthcare.

I am the co-director of Innovations in Community Research in Cincinnati Children’s Division of Behavioral Medicine and Clinical Psychology. I also direct Cincinnati Children’s Center for Clinical and Translational Science and Training (CCTST) Community Engagement Core where I help the community and researchers work together on health projects.

I was inspired to work with young people after I lost a childhood friend to cancer. I chose to do research because I wanted to help as many children and families as I could. With my research, I strive to learn the best ways for the medical team and patients and families to work together to improve treatment and the family's quality of life.

My areas of research interest include self-management, treatment adherence, healthcare transition, recruitment and retention of minorities in research, integrating design thinking into research, implementation science and community engagement.

I hope to find answers to a number of questions with my research, including:

  • How do we engage adolescents and young adults with sickle cell disease in managing their condition?
  • How can we facilitate shared decision-making between providers and families of youth with sickle cell disease?
  • How can we make it easier for youth to follow their medical regime?
  • How can patients, families and advocacy groups partner with academic researchers to solve health challenges?
  • How do bias and other systemic factors impact care and outcomes for vulnerable or underserved populations?
  • How can we integrate technology so we can reach more individuals/communities?

Engaging patients and communities allows us to develop innovative and feasible solutions to health challenges.

I am proud to be an elected fellow of the American Psychological Association (APA) and to have received their Division 54 Diversity Award. I’m also a committee member for the National Academies of Sciences, Engineering, and Medicine’s effort titled Addressing Sickle Cell Disease: A Strategic Plan and Blueprint for Action.

PsyD: Wright State University, Dayton, Ohio, 1995.

Residency: Cincinnati Children's Hospital Medical Center, Cincinnati, OH.

Fellowship: Clinical Psychology, INTERACT Behavioral Healthcare Services Inc, Columbus, OH, 1995-1996.

Interests

Adolescents and young adults; sickle cell disease; transition to adult care; chronic pain; migraines; diversity and inclusion

Services and Specialties

Behavioral Medicine, Behavioral Medicine and Clinical Psychology

Interests

Community-engaged research; self-management; quality improvement; sickle cell disease; health disparities; patient centered outcomes; shared decision making; health services research

Research Areas

Clinical Psychology, Adherence and Self-Management

Insurance Information

Cincinnati Children's strives to accept a wide variety of health plans. Please contact your health insurance carrier to verify coverage for your specific benefit plan.

View Insurance Information

Publications

Editorial: Recommendations on inclusive language and transparent reporting relating to diversity dimensions for the Journal of Pediatric Psychology and Clinical Practice in Pediatric Psychology. Modi, AC; Beal, SJ; Becker, SP; Boerner, KE; Burton, ET; Chen, D; Crosby, LE; Hilliard, ME; Hood, AM; Kahhan, NA; et al. Journal of Pediatric Psychology. 2024; 49:1-12.

An Updated Equitable Model of Readiness for Transition to Adult Care: Content Validation in Young People With Sickle Cell Disease. Prussien, KV; Crosby, LE; Faust, HL; Barakat, LP; Deatrick, JA; Smith-Whitley, K; Schwartz, LA. JAMA Pediatrics. 2024; 178.

The effect of an adapted digital mental health intervention for sickle cell disease on engagement: a pilot randomized controlled trial. Nardo, EV; Parchuri, E; O’Brien, JA; Crosby, L; Porter, J; Palermo, T; Nikolajski, C; Treadwell, M; Hillery, CA; Szigethy, E; et al. 2023; 1:54.

Feasibility of Electronic Medication Monitoring Among Adolescents and Emerging Adults with Sickle Cell Disease. Hildenbrand, AK; Kidwell, KM; McGrady, ME; Quinn, CT; Crosby, LE; Mara, CA. Patient Preference and Adherence. 2023; 17:3167-3171.

Evaluation of a Community COVID-19 Vaccine Ambassador Train-the-Trainer Program. Corley, AM S; Gomes, SM; Martin, KJ; Watkins, S; Lindsey, K; Frenck, RW; Mitchell, MJ; Rule, AR L; Crosby, LE. Journal of Immigrant Health. 2023; 25:1302-1306.

Taking Shared Decision Making from Concept to Clinical Practice: What Do Sickle Cell Healthcare Providers Need?. Hildenbrand, AK; Bear, B; Lewis, AM; Schultz, CL; Alderfer, MA; Crosby, LE. Blood. 2023; 142:5054.

SCD and COVID-19 Vaccines: What Do Pediatric Patients Want to Know?. Shook, LM; Lang, A; King, AA; Smith-Whitley, K; Thompson, AA; Barriteau, CM; Schwartz, L; Mosely, C; Oke, E; Jallow, F; et al. Blood. 2023; 142:7199.

Patterns of Nonadherence to Hydroxyurea in Pediatric Sickle Cell Disease. Crosby, LE; Lang, A; Mara, C; Quinn, CT; Schultz, CL; Bear, B; Akintobi, TE; Miller, RE; Hildenbrand, AK. Blood. 2023; 142:7198.

Disease-Modifying Therapies for Sickle Cell Disease: Decisional Needs and Supports Among Adolescents and Young Adults. Ding, K; Bear, B; Sood, E; Alderfer, MA; Crosby, LE; Hildenbrand, AK. Blood. 2023; 142:5059.

Assessing Psychosocial Readiness for Gene Therapy in Sickle Cell Disease: A Consensus Statement. Hardy, SJ; Crosby, LE; Porter, JS; Sil, S; Valrie, CR; Jonassaint, CR; Bediako, SM; Andrews, C; Rivera, M; Woolford, T; et al. Blood. 2023; 142:371.

Patient Ratings and Comments

All patient satisfaction ratings and comments are submitted by actual patients and verified by a leading independent patient satisfaction company, NRC Health. Patient identities are withheld to ensure confidentiality and privacy. Only those providers whose satisfaction surveys are administered through Cincinnati Children’s Hospital Medical Center are displayed. Click here to learn more about our survey

4.6
Overall Patient Rating